Docket Room
HR 9937·Federal·house

No Leniency for Fentanyl Dealers Act

In CommitteeFiled Jul 23, 2026
Sponsor: Rep. Stutzman, Marlin A. [R-IN-3] (R)
Latest Action

Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jul 23, 2026

Summary

The bill would revise the Controlled Substances Act and the Controlled Substances Import and Export Act to alter how fentanyl offenses are defined and punished. It would affect anyone subject to federal fentanyl regulations—including manufacturers, distributors, and users—by updating the legal framework for violations. The change aims to address concerns about fentanyl trafficking and abuse.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 9937 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice